; or (6) that, in the case of a drug that is or contains a controlled substance for which a listing in any schedule is in effect under the Controlled Substances Act or that is permanently scheduled pursuant to section 201 of such Act, on the basis of new information before him with respect to such drug, evaluated together with the information available to him when the application was approved, that the drug is unsafe for use due to the risks of abuse or misuse after of a material fact . (c) Rule of construction Nothing in the amendments made by this section shall be construed to limit or narrow, in any manner, the meaning or application of the provisions of paragraphs (1), (2), (3), (4), (5), and (7) of section 505(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(d) ) or paragraphs (1) and (2) of section 505(e) of such Act ( 21 U.S.C. 355(e) ). L Treatment, Education, and Community Help to Combat Addiction 7111. Short title This subtitle may be cited as the Treatment, Education, and Community Help to Combat Addiction Act of 2018 or the TEACH to Combat Addiction Act of 2018 . 7112. Establishment of Regional Centers of Excellence in Substance Use Disorder Education Part D of title V of the Public Health Service Act is amended by inserting after section 549 ( 42 U.S.C. 290ee–4 ) the following new section: 550. Regional Centers of Excellence in Substance Use Disorder Education (a) In general The Secretary, in consultation with such other agencies as are appropriate, shall, subject to the availability of appropriations, establish a solicitation process and award cooperative agreements to eligible entities for the designation of such entities as Regional Centers of Excellence in Substance Use Disorder Education and support of such regional centers of excellence to enhance and improve how health professionals are educated in substance use disorder prevention, treatment, and recovery through development, evaluation, and distribution of evidence-based curricula for health profession schools. An eligible